|
KLF13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.10459999322654E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03700004139284E-09 |
| Normal-vs-Stage2 |
5.98010000407712E-08 |
| Normal-vs-Stage3 |
6.80040468381549E-11 |
| Normal-vs-Stage4 |
2.33819996697804E-09 |
| Stage1-vs-Stage2 |
8.384600E-01 |
| Stage1-vs-Stage3 |
1.368990E-01 |
| Stage1-vs-Stage4 |
6.140200E-01 |
| Stage2-vs-Stage3 |
2.223400E-01 |
| Stage2-vs-Stage4 |
5.868600E-01 |
| Stage3-vs-Stage4 |
5.510000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.00099969716439E-10 |
| Normal-vs-AfricanAmerican |
1.84889999998994E-06 |
| Normal-vs-Asian |
1.1598000004831E-08 |
| Caucasian-vs-AfricanAmerican |
5.979600E-01 |
| Caucasian-vs-Asian |
9.151000E-01 |
| AfricanAmerican-vs-Asian |
6.977200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.23520005335109E-09 |
| Normal-vs-Female |
3.90020016283188E-10 |
| Male-vs-Female |
8.384800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.82790002525957E-09 |
| Normal-vs-Age(41-60Yrs) |
3.64229979510355E-10 |
| Normal-vs-Age(61-80Yrs) |
9.1799012835736E-11 |
| Normal-vs-Age(81-100Yrs) |
7.424700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.493000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.202020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.370800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.258400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.976200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.654800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.516590E-01 |
| Classical-VS-Follicular |
5.493700E-02 |
| Classical-VS-Other |
4.166200E-01 |
| Classical-VS-Normal |
4.88929996489418E-09 |
| Tall-VS-Follicular |
8.726200E-01 |
| Tall-VS-Other |
9.270800E-01 |
| Tall-VS-Normal |
6.23819995659858E-10 |
| Follicular-VS-Other |
8.698800E-01 |
| Follicular-VS-Normal |
2.27819985099131E-10 |
| Other-VS-Normal |
3.224000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.72310055113201E-10 |
| Normal-vs-N1 |
6.49809994701656E-09 |
| N0-vs-N1 |
9.720400E-01 |
|
|
